AAAAAA

   
Results: 1-7 |
Results: 7
Support groups for people carrying a BRCA mutation - The authors respond
Authors: Di Prospero, LS Seminsky, M Honeyford, J Doan, B Franssen, E Meschino, W Chart, P Warner, E Esplen, MJ
Citation: Ls. Di Prospero et al., Support groups for people carrying a BRCA mutation - The authors respond, CAN MED A J, 165(6), 2001, pp. 740
Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey
Authors: Di Prospero, LS Seminsky, M Honeyford, J Doan, B Franssen, E Meschino, W Chart, P Warner, E
Citation: Ls. Di Prospero et al., Psychosocial issues following a positive result of genetic testing for BRCA1 and BRCA2 mutations: findings from a focus group and a needs-assessment survey, CAN MED A J, 164(7), 2001, pp. 1005-1009
Screening for PS1 mutations in a referral-based series of AD cases - 21 Novel mutations
Authors: Rogaeva, EA Fafel, KC Song, YQ Medeiros, H Sato, C Liang, Y Richard, E Rogaev, EI Frommelt, P Sadovnick, AD Meschino, W Rockwood, K Boss, MA Mayeux, R St George-Hyslop, P
Citation: Ea. Rogaeva et al., Screening for PS1 mutations in a referral-based series of AD cases - 21 Novel mutations, NEUROLOGY, 57(4), 2001, pp. 621-625
Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1
Authors: Bourdeau, A Cymerman, U Paquet, ME Meschino, W McKinnon, WC Guttmacher, AE Becker, L Letarte, M
Citation: A. Bourdeau et al., Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1, AM J PATH, 156(3), 2000, pp. 911-923
Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer
Authors: Warner, E Foulkes, W Goodwin, P Meschino, W Blondal, J Paterson, C Ozcelik, H Goss, P Allingham-Hawkins, D Hamel, N Di Prospero, L Contiga, V Serruya, C Klein, M Moslehi, R Honeyford, J Liede, A Glendon, C Brunet, JS Narod, S
Citation: E. Warner et al., Prevalence and penetrance of BRCA1 and BRCA2 gene mutations in unselected Ashkenazi Jewish women with breast cancer, J NAT CANC, 91(14), 1999, pp. 1241-1247
Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased A beta 42 secretion
Authors: De Jonghe, C Cruts, M Rogaeva, EA Tysoe, C Singleton, A Vanderstichele, H Meschino, W Dermaut, D Vanderhoeven, I Backhovens, H Vanmechelen, E Morris, CM Hardy, J Rubinsztein, DC St George-Hyslop, PH Van Broeckhoven, C
Citation: C. De Jonghe et al., Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimer's disease by increased A beta 42 secretion, HUM MOL GEN, 8(8), 1999, pp. 1529-1540
The importance of a family history of breast cancer in predicting the presence of a BRCA mutation
Authors: Foulkes, WD Brunet, JS Warner, E Goodwin, PJ Meschino, W Narod, SA Goss, PE Glendon, G
Citation: Wd. Foulkes et al., The importance of a family history of breast cancer in predicting the presence of a BRCA mutation, AM J HU GEN, 65(6), 1999, pp. 1776-1779
Risultati: 1-7 |